Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Long-Term, Open-Label Study to Assess the Safety and Tolerability of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2026-04-23Electroconvulsive Therapy Versus Magnetic Seizure Therapy: Clinical and Cognitive Outcomes
-
CLINICAL_TRIALS study record update · 2026-04-23Stony Brook Medicine Anti-Inflammatory Trial
-
CLINICAL_TRIALS study record update · 2026-04-22Defining Neurobiological Links Between Substance Use and Mental Illness
-
CLINICAL_TRIALS study record update · 2026-04-22Empower: Transcranial Direct Current Stimulation in Major Depressive Disorder: a Double-blind, Placebo-controlled, Randomized, Superiority Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-21IPT for Major Depression Following Perinatal Loss: Healing After Loss (HeAL)
-
CLINICAL_TRIALS study record update · 2026-04-21An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression
-
CLINICAL_TRIALS study record update · 2026-04-21Comparison of Venous Tourniquet Method With Isolated Forearm Technique in Electroconvulsive Therapy in Terms of Efficacy and Safety
-
CLINICAL_TRIALS study record update · 2026-04-21EXPERIMENTAL ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION: AFFECTIVE, NEURAL, AND INFLAMMATORY MECHANISMS
-
CLINICAL_TRIALS study record update · 2026-04-21Neural Response to Inflammatory Challenge in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-20Natural History of Depression, Bipolar Disorder and Suicide Risk
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients: Part I Dose Escalation
-
CLINICAL_TRIALS study record update · 2026-04-20Tracking Brain Biomarkers and Renormalization Associated With Antidepressant Transcranial Magnetic Stimulation Therapy
-
CLINICAL_TRIALS study record update · 2026-04-17A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression - DEPRE-ST*Case
-
CLINICAL_TRIALS study record update · 2026-04-17Hybrid Effectiveness-Implementation Trial to Evaluate a Scalable, Peer-Delivered Intervention for Depression Among People With Substance Use Disorder in a Certified Community Behavioral Health Clinic
-
CLINICAL_TRIALS study record update · 2026-04-17Double-Blind, Single and Multiple Dose Study to Determine Pharmacodynamic Markers, Pharmacokinetic Parameters, and Safety of ALTO-203 in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-17Clinical Validation of Samsung Smartwatch
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-15Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation and Recovery Centers
-
CLINICAL_TRIALS study record update · 2026-04-15A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2026-04-14VR-Moodboost in the Treatment of Depression; a Proof-of-concept Study
-
CLINICAL_TRIALS study record update · 2026-04-14Early TMS-EEG Potentials as Biomarkers for Personalized Neuromodulation in Treatment-Resistant Depression (R61 Phase)
-
CLINICAL_TRIALS study record update · 2026-04-13Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms and Improve Brain Circuitry Functioning
-
CLINICAL_TRIALS study record update · 2026-04-13Randomized, Cross-over, Placebo-controlled Trial to Determine Target Engagement and Dose Response of Optimized Closed-loop rTMS for Medication-resistant Depression